These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 8196573)

  • 41. Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer.
    Murphy RL; Lavelle JP; Allan JD; Gordin FM; Dupliss R; Boswell SL; Waskin HA; Davies SF; Graziano FM; Saag MS
    Am J Med; 1991 Apr; 90(4):418-26. PubMed ID: 2012082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D
    Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
    Jubault V; Pacanowski J; Rabian C; Viard JP
    Ann Med Interne (Paris); 2000 May; 151(3):163-8. PubMed ID: 10896967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
    Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P
    J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia.
    Fahy JV; Chin DP; Schnapp LM; Steiger DJ; Schaumberg TH; Geaghan SM; Klein JS; Hopewell PC
    Am Rev Respir Dis; 1992 Oct; 146(4):844-8. PubMed ID: 1416408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
    Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
    Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience with pneumocystis carinii pneumonia in patients with AIDS.
    Ingram RJ; Davis R; Ellis-Pegler RB
    N Z Med J; 1989 Sep; 102(876):496-8. PubMed ID: 2797573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of aerosol pentamidine prophylaxis.
    Ong EL
    Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of mild to moderately severe Pneumocystis carinii pneumonia with cotrimoxazole versus pentamidine aerosol. Preliminary results of a prospective randomized therapy study].
    Arasteh K; Heise W; L'age M
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():260-3. PubMed ID: 2197535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.
    Eigenmann C; Flepp M; Bernasconi E; Schiffer V; Telenti A; Bucher H; Wagels T; Egger M; Furrer H;
    Clin Infect Dis; 2003 Apr; 36(7):917-21. PubMed ID: 12652393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF).
    Stoehr A; Arasteh K; Staszewski S; Brockmeyer N; Albrecht H; Mertenskötter T; Jablonowski H; Emminger C; Rockstroh JK; Baumgarten R; Bogner J; Loch T; Plettenberg A
    Eur J Med Res; 1999 Apr; 4(4):131-4. PubMed ID: 10205287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of aerosol pentamidine: a program design.
    O'Hara CM; Anton WR; Gormley FX; Brazell C
    J Assoc Nurses AIDS Care; 1994; 5(2):41-8. PubMed ID: 8032012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency.
    Casale L; Gold H; Schechter C; Naficy A; Masci JR
    Chest; 1993 Feb; 103(2):342-4. PubMed ID: 8094333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese.
    Konishi M; Yoshimoto E; Takahashi K; Uno K; Kasahara K; Murakawa K; Maeda K; Mikasa K; Narita N
    J Infect Chemother; 2003 Jun; 9(2):178-82. PubMed ID: 12825119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pentamidine aerosol to prevent Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1989 Oct; 31(802):91-2. PubMed ID: 2571064
    [No Abstract]   [Full Text] [Related]  

  • 57. Pneumocystis carinii pleuropneumonia after aerosolized pentamidine prophylaxis.
    Ewig S; von Kempis J; Rockstroh J; Steudel A; Vogel J; Niese D
    Infection; 1991; 19(6):442-4. PubMed ID: 1816116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pneumocystitis carinii pneumonia in adult patients with AIDS].
    Møller A; Seefeldt-Nielsen T; Andersen PL; Black FT
    Ugeskr Laeger; 1991 Jun; 153(24):1710-1. PubMed ID: 2058040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 60. Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
    Mussini C; Pezzotti P; Antinori A; Borghi V; Monforte Ad; Govoni A; De Luca A; Ammassari A; Mongiardo N; Cerri MC; Bedini A; Beltrami C; Ursitti MA; Bini T; Cossarizza A; Esposito R;
    Clin Infect Dis; 2003 Mar; 36(5):645-51. PubMed ID: 12594647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.